Adaptive Biotech director gifts 12,539 shares
Adaptive Biotechnologies Corp (ADPT) director Katey Einterz Owen reported a bona fide gift of 12,539 shares of common stock on August 31, 2026.
Rhea-AI Filing Summary
Adaptive Biotechnologies Corp (ADPT) director Katey Einterz Owen reported a bona fide gift of 12,539 shares of common stock on August 31, 2026. The transaction was a disposition by gift, not a sale for value, and Owen now holds 66,100 shares of Adaptive Biotechnologies common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
12,539 shares gifted
Gift
1 txn
Insider
OWEN KATEY EINTERZ
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock F1 | 12,539 | -- | -- |
Holdings After Transaction:
Common Stock — 66,100 shares (Direct)
Footnotes (1)
- F1. Price is not applicable to dispositions resulting from bona fide gifts.
Key Figures
Shares gifted: 12,539 shares
Shares held after transaction: 66,100 shares
Gift transactions count: 1 transaction
+1 more
4 metrics
Shares gifted
12,539 shares
Bona fide gift of common stock on August 31, 2026
Shares held after transaction
66,100 shares
Direct holdings of common stock following the reported gift
Gift transactions count
1 transaction
Number of bona fide gift transactions reported in this Form 4
Gift shares total
12,539 shares
Total shares reported as bona fide gifts in this Form 4
Key Terms
bona fide gift, Rule 10b5-1, Form 4, non-derivative
4 terms
bona fide gift regulatory
"The transaction is reported with code G, described as a bona fide gift"
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
Rule 10b5-1 regulatory
"The Rule 10b5-1 checkbox is not marked for this transaction"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Form 4 regulatory
"Post-transaction holdings are stated in the Form 4"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
non-derivative financial
"The gift involves a non-derivative holding of common stock"
FAQ
What insider transaction did ADPT director Katey Einterz Owen report?
Katey Einterz Owen reported a bona fide gift of Adaptive Biotechnologies common stock on August 31, 2026, transferring shares as a gift rather than selling them for cash consideration.
Was the ADPT insider transaction made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that the Rule 10b5-1 checkbox is not marked, so the reported bona fide gift of 12,539 shares was not affirmatively reported as being made under a Rule 10b5-1 trading plan.
What type of code is used for the ADPT insider transaction?
The transaction is reported with code G, which the form describes as a bona fide gift. This indicates a charitable or other gift disposition of shares rather than an open-market purchase or sale.
Does the Form 4 for ADPT disclose any option exercises or derivative transactions?
No. The Form 4 summary shows no derivative transactions and no option exercises; it reports only one non-derivative transaction, the bona fide gift of 12,539 common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
